Sitavig
Product Images NDC 68712-049

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sitavig (NDC 68712-049). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipher Pharmaceuticals Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Fig A (Fig A)

Fig A (Fig A)
An instructional illustration showing a hand placing a Sitavig tablet inside the mouth onto the gum area. The image includes a label pointing to the application site indicating 'Area to apply SITAVIG tablet.' This diagram demonstrates the correct placement of the tablet for administration.*
FDA Label Image

Fig B (Fig B)

Fig B (Fig B)
Sitavig is shown as a white, round, beveled tablet with a flat top and bottom surface. The image displays two perspectives: one side view and one top-side angle, highlighting the tablet's shape and beveling. No text or markings are visible on the tablet itself.*
FDA Label Image

Fig C (Fig C)

Fig C (Fig C)
An instructional illustration showing the placement of a medication tablet inside the mouth, specifically onto the upper gum or oral mucosa. The image depicts a person holding a round tablet with two fingers, about to apply it to the gum area above the upper teeth.*
FDA Label Image

Fig D (Fig D)

Fig D (Fig D)
An instructional illustration showing a person placing a tablet on the upper gum above the incisor teeth. The image demonstrates the proper placement technique likely for the Sitavig buccal tablet.*
FDA Label Image

Image Description (Sitavig Box 1015 Cr)

Image Description (Sitavig Box 1015 Cr)
Packaging label for Sitavig 50 mg buccal tablets containing acyclovir, distributed by Cipher Pharmaceuticals U.S. LLC. The label states 2 blisters, each containing one 50 mg buccal tablet, includes dosage and storage instructions, and displays the NDC 68712-049-02 along with a barcode.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure diagram of the active ingredient found in Sitavig, illustrating a molecular structure with multiple rings, including nitrogen and oxygen atoms, characteristic of an antiviral agent.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.